IP Library Granted Patent US 11,807,897
Granted Patent B2
US 11,807,897 · App. 16/590,878 · Granted Nov 7, 2023

Methods of preparing nucleic acids for sequencing

Inventors: Anthony John Iafrate (Newton, MA); Long Phi Le (Boston, MA); Zongli Zheng (Boston, MA); Jason Myers (Golden, CO); Joshua Stahl (Boulder, CO)
Assignees: The General Hospital Corporation; ARCHERDX, LLC
C12Q1/6806C12Q1/6809
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,807,897
App. No.
16/590,878
Granted
Nov 7, 2023
Kind
B2
Abstract

Aspects of the technology disclosed herein relate to methods for preparing and analyzing nucleic acids. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.

Claims (14)

1. A method of determining the nucleotide sequence contiguous to a known target nucleotide sequence, the method comprising:

(a) contacting a target nucleic acid molecule comprising the known target nucleotide sequence with an initial target-specific primer under hybridization conditions;

(b) performing a template-dependent extension reaction that is primed by a hybridized initial target-specific primer and that uses the target nucleic acid molecule as a template;

(c) contacting an extension product of step (b) with a plurality of tailed random primers under hybridization conditions;

(d) performing a template-dependent extension reaction that is primed by a hybridized tailed random primer and that uses the extension product of step (b) as a template;

(e) amplifying a portion of an extension product of step (d) with a first tail primer and a first target-specific primer; and

(f) sequencing an amplification product from step (e) using a first or second sequencing primer;

wherein each of the plurality of tailed random primers comprises (i) a common sequence and (ii) a 3′-end comprising about 3 to about 15 random nucleotides;

wherein the initial target-specific primer comprises a nucleic acid sequence that can specifically anneal to the known target nucleotide sequence of the target nucleic acid;

wherein the first target-specific primer comprises a 3′ portion comprising a nucleic acid sequence that can specifically anneal to a portion of the known target nucleotide sequence and is nested with respect to the initial target-specific primer; and

wherein the first tail primer comprises a nucleic acid sequence identical to a portion of the common sequence.

2. The method of claim 1 , wherein each of the plurality of tailed random primers comprises a barcode or index sequence between the common sequence and the 3′-end.

3. The method of claim 1 , wherein the first target-specific primer is nested with respect to the initial target-specific primer by at least 3 nucleotides.

4. The method of claim 1 , wherein each of the plurality of tailed random primers consists of naturally occurring nucleotides.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2025
From: ARCHERDX, LLC
To: INVITAE CORPORATION
Reel/Frame 073239/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2024
From: INVITAE CORPORATION
To: LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 068822/0025 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0095 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0442 →
MERGER AND CHANGE OF NAME Recorded Oct 2, 2020
From: ARCHERDX, INC.; APOLLO MERGER SUB B LLC
To: ARCHERDX, LLC
Reel/Frame 053965/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2019
From: MYERS, JASON; STAHL, JOSHUA
To: ARCHERDX, INC.
Reel/Frame 050606/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2019
From: IAFRATE, ANTHONY JOHN; LE, LONG PHI; ZHENG, ZONGLI
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 050606/0809 →
Cited By (1)
US 12,630,864